Biological specimen banks in neonatal screening

The Danish neonatal screening program analyses dried blood spot samples (DBSS) from close to 70 000 newborns annually from Denmark, Greenland and the Faroe Islands. Since 1982, all DBSS have been stored in a biological specimen bank at −20°C as a routine procedure after analysis. Before sampling, pa...

Full description

Bibliographic Details
Published in:Acta Paediatrica
Main Authors: Nørgaard‐Pedersen, B, Simonsen, H
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 1999
Subjects:
Online Access:http://dx.doi.org/10.1111/j.1651-2227.1999.tb01172.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.1999.tb01172.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1651-2227.1999.tb01172.x
id crwiley:10.1111/j.1651-2227.1999.tb01172.x
record_format openpolar
spelling crwiley:10.1111/j.1651-2227.1999.tb01172.x 2024-09-15T18:05:41+00:00 Biological specimen banks in neonatal screening Nørgaard‐Pedersen, B Simonsen, H 1999 http://dx.doi.org/10.1111/j.1651-2227.1999.tb01172.x https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.1999.tb01172.x https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1651-2227.1999.tb01172.x en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor Acta Paediatrica volume 88, issue s432, page 106-109 ISSN 0803-5253 1651-2227 journal-article 1999 crwiley https://doi.org/10.1111/j.1651-2227.1999.tb01172.x 2024-09-05T05:10:47Z The Danish neonatal screening program analyses dried blood spot samples (DBSS) from close to 70 000 newborns annually from Denmark, Greenland and the Faroe Islands. Since 1982, all DBSS have been stored in a biological specimen bank at −20°C as a routine procedure after analysis. Before sampling, parents are given written information about the screening tests, the biobank and its use, and can choose to opt out. Since 1993 the biobank has been regulated by specific legislation, and thus assumes a unique position among biological specimen banks. Its purposes are: (i) diagnosis and treatment of diseases screened for, including repeat testing, quality assurance and group statistics; (ii) other diagnostic uses during infancy; and (iii) research projects. The stored samples have been used successfully to diagnose a range of genetic diseases using biochemical and molecular genetic assays, and to diagnose congenital CMV and toxoplasmosis infections using assays for specific IgM antibodies and pathogen nucleic acids. The unbiased nature and comprehensive coverage of the samples in the biobank make them attractive for research purposes. Our studies have focused on the epidemiology of genetic disease alleles and other molecular disease markers and on retrospective screening projects, which have allowed rapid appraisal of the performance of novel screening modalities, saving years of prospective screening trials. Storage of neonatal screening samples is thus beneficial not only to the individual testees, but also to future generations of newborns. Article in Journal/Newspaper Faroe Islands Greenland Wiley Online Library Acta Paediatrica 88 s432 106 109
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description The Danish neonatal screening program analyses dried blood spot samples (DBSS) from close to 70 000 newborns annually from Denmark, Greenland and the Faroe Islands. Since 1982, all DBSS have been stored in a biological specimen bank at −20°C as a routine procedure after analysis. Before sampling, parents are given written information about the screening tests, the biobank and its use, and can choose to opt out. Since 1993 the biobank has been regulated by specific legislation, and thus assumes a unique position among biological specimen banks. Its purposes are: (i) diagnosis and treatment of diseases screened for, including repeat testing, quality assurance and group statistics; (ii) other diagnostic uses during infancy; and (iii) research projects. The stored samples have been used successfully to diagnose a range of genetic diseases using biochemical and molecular genetic assays, and to diagnose congenital CMV and toxoplasmosis infections using assays for specific IgM antibodies and pathogen nucleic acids. The unbiased nature and comprehensive coverage of the samples in the biobank make them attractive for research purposes. Our studies have focused on the epidemiology of genetic disease alleles and other molecular disease markers and on retrospective screening projects, which have allowed rapid appraisal of the performance of novel screening modalities, saving years of prospective screening trials. Storage of neonatal screening samples is thus beneficial not only to the individual testees, but also to future generations of newborns.
format Article in Journal/Newspaper
author Nørgaard‐Pedersen, B
Simonsen, H
spellingShingle Nørgaard‐Pedersen, B
Simonsen, H
Biological specimen banks in neonatal screening
author_facet Nørgaard‐Pedersen, B
Simonsen, H
author_sort Nørgaard‐Pedersen, B
title Biological specimen banks in neonatal screening
title_short Biological specimen banks in neonatal screening
title_full Biological specimen banks in neonatal screening
title_fullStr Biological specimen banks in neonatal screening
title_full_unstemmed Biological specimen banks in neonatal screening
title_sort biological specimen banks in neonatal screening
publisher Wiley
publishDate 1999
url http://dx.doi.org/10.1111/j.1651-2227.1999.tb01172.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.1999.tb01172.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1651-2227.1999.tb01172.x
genre Faroe Islands
Greenland
genre_facet Faroe Islands
Greenland
op_source Acta Paediatrica
volume 88, issue s432, page 106-109
ISSN 0803-5253 1651-2227
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1111/j.1651-2227.1999.tb01172.x
container_title Acta Paediatrica
container_volume 88
container_issue s432
container_start_page 106
op_container_end_page 109
_version_ 1810443210632200192